Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

276 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Identification of clinical factors related to antibody-mediated immune response to the subfornical organ.
Nakamura-Utsunomiya A, Goda S, Hayakawa S, Sonoko S, Hoorn EJ, Blanchard A, Saito-Hakoda A, Kakimoto H, Hachiya R, Kamimura M, Kawakita R, Higuchi S, Fujimaru R, Shirai Y, Miyaoka D, Nagata Y, Kishi Y, Wada A, Mitsuboshi A, Ozaki K, Komatsu N, Niizuma H, Kanno J, Fujiwara I, Hasegawa Y, Yorifuji T, Brickman W, Vantyghem MC, Yamaguchi K, Goshima N, Hiyama TY. Nakamura-Utsunomiya A, et al. Among authors: vantyghem mc. Clin Endocrinol (Oxf). 2022 Jul;97(1):72-80. doi: 10.1111/cen.14737. Epub 2022 Apr 22. Clin Endocrinol (Oxf). 2022. PMID: 35419873
Efficacy of lanreotide 120 mg primary therapy on tumour shrinkage and ophthalmologic symptoms in acromegaly after 1 month.
Benderradji H, Vernotte E, Soto Ares G, Woillez JP, Jannin A, Perbet R, Karnoub MA, Soudan B, Assaker R, Buée L, Prevot V, Maurage CA, Pigny P, Vantyghem MC, Merlen E, Cortet C. Benderradji H, et al. Among authors: vantyghem mc. Clin Endocrinol (Oxf). 2022 Jul;97(1):52-63. doi: 10.1111/cen.14748. Epub 2022 May 5. Clin Endocrinol (Oxf). 2022. PMID: 35470446
Diagnostic Challenge in PLIN1-Associated Familial Partial Lipodystrophy.
Jéru I, Vantyghem MC, Bismuth E, Cervera P, Barraud S; PLIN1-Study Group; Auclair M, Vatier C, Lascols O, Savage DB, Vigouroux C. Jéru I, et al. Among authors: vantyghem mc. J Clin Endocrinol Metab. 2019 Dec 1;104(12):6025-6032. doi: 10.1210/jc.2019-00849. J Clin Endocrinol Metab. 2019. PMID: 31504636 Free PMC article.
Phakomatoses and Endocrine Gland Tumors: Noteworthy and (Not so) Rare Associations.
Chevalier B, Dupuis H, Jannin A, Lemaitre M, Do Cao C, Cardot-Bauters C, Espiard S, Vantyghem MC. Chevalier B, et al. Among authors: vantyghem mc. Front Endocrinol (Lausanne). 2021 May 6;12:678869. doi: 10.3389/fendo.2021.678869. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34025587 Free PMC article. Review.
Examination of the Igls Criteria for Defining Functional Outcomes of β-cell Replacement Therapy: IPITA Symposium Report.
Landstra CP, Andres A, Chetboun M, Conte C, Kelly Y, Berney T, de Koning EJP, Piemonti L, Stock PG, Pattou F, Vantyghem MC, Bellin MD, Rickels MR. Landstra CP, et al. Among authors: vantyghem mc. J Clin Endocrinol Metab. 2021 Sep 27;106(10):3049-3059. doi: 10.1210/clinem/dgab386. J Clin Endocrinol Metab. 2021. PMID: 34061967 Free PMC article.
Beyond MEN1, when to think about MEN4? Retrospective study on 5600 patients in the French population & literature review.
Chevalier B, Coppin L, Romanet P, Cuny T, Maiza JC, Abeillon J, Forestier J, Walter T, Gilly O, Le Bras M, Smati S, Nunes ML, Geslot A, Grunenwald S, Mouly C, Arnault G, Wagner K, Koumakis E, Cortet-Rudelli C, Merlen É, Jannin A, Espiard S, Morange I, Baudin É, Cavaille M, Tauveron I, Teissier MP, Borson-Chazot F, Mirebeau-Prunier D, Savagner F, Pasmant É, Giraud S, Vantyghem MC, Goudet P, Barlier A, Cardot-Bauters C, Odou MF. Chevalier B, et al. Among authors: vantyghem mc. J Clin Endocrinol Metab. 2024 Jan 30:dgae055. doi: 10.1210/clinem/dgae055. Online ahead of print. J Clin Endocrinol Metab. 2024. PMID: 38288531
Lessons from prospective longitudinal follow-up of a French APECED cohort.
Humbert L, Proust-Lemoine E, Dubucquoi S, Kemp EH, Saugier-Veber P, Fabien N, Raymond-Top I, Cardot-Bauters C, Carel JC, Cartigny M, Chabre O, Chanson P, Delemer B, Do Cao C, Guignat L, Kahn JE, Kerlan V, Lefebvre H, Linglart A, Mallone R, Reynaud R, Sendid B, Souchon PF, Touraine P, Wémeau JL, Vantyghem MC. Humbert L, et al. Among authors: vantyghem mc. J Clin Endocrinol Metab. 2024 Apr 12:dgae211. doi: 10.1210/clinem/dgae211. Online ahead of print. J Clin Endocrinol Metab. 2024. PMID: 38605470 Free article.
Autosomal dominant resistance to thyrotropin as a distinct entity in five multigenerational kindreds: clinical characterization and exclusion of candidate loci.
Grasberger H, Mimouni-Bloch A, Vantyghem MC, van Vliet G, Abramowicz M, Metzger DL, Abdullatif H, Rydlewski C, Macchia PE, Scherberg NH, van Sande J, Mimouni M, Weiss RE, Vassart G, Refetoff S. Grasberger H, et al. Among authors: vantyghem mc. J Clin Endocrinol Metab. 2005 Jul;90(7):4025-34. doi: 10.1210/jc.2005-0572. Epub 2005 May 3. J Clin Endocrinol Metab. 2005. PMID: 15870119 Free article.
New metabolic phenotypes in laminopathies: LMNA mutations in patients with severe metabolic syndrome.
Decaudain A, Vantyghem MC, Guerci B, Hécart AC, Auclair M, Reznik Y, Narbonne H, Ducluzeau PH, Donadille B, Lebbé C, Béréziat V, Capeau J, Lascols O, Vigouroux C. Decaudain A, et al. Among authors: vantyghem mc. J Clin Endocrinol Metab. 2007 Dec;92(12):4835-44. doi: 10.1210/jc.2007-0654. Epub 2007 Aug 21. J Clin Endocrinol Metab. 2007. PMID: 17711925
276 results